These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 37789862)

  • 1. Beyond antibiotics: phage-encoded lysins against Gram-negative pathogens.
    Shah S; Das R; Chavan B; Bajpai U; Hanif S; Ahmed S
    Front Microbiol; 2023; 14():1170418. PubMed ID: 37789862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liposomal Delivery of Newly Identified Prophage Lysins in a
    Morais D; Tanoeiro L; Marques AT; Gonçalves T; Duarte A; Matos APA; Vital JS; Cruz MEM; Carvalheiro MC; Anes E; Vítor JMB; Gaspar MM; Vale FF
    Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077542
    [No Abstract]   [Full Text] [Related]  

  • 3. Gram-Negative Bacterial Lysins.
    Ghose C; Euler CW
    Antibiotics (Basel); 2020 Feb; 9(2):. PubMed ID: 32054067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engineering a Lysin with Intrinsic Antibacterial Activity (LysMK34) by Cecropin A Fusion Enhances Its Antibacterial Properties against Acinetobacter baumannii.
    Abdelkader K; Gutiérrez D; Tamés-Caunedo H; Ruas-Madiedo P; Safaan A; Khairalla AS; Gaber Y; Dishisha T; Briers Y
    Appl Environ Microbiol; 2022 Jan; 88(1):e0151521. PubMed ID: 34669452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Phage Lysin Abp013 against
    Chu JJK; Poh WH; Hasnuddin NTB; Hew EY; Dam LC; Sahili AE; Rice SA; Goh BC
    Antibiotics (Basel); 2022 Jan; 11(2):. PubMed ID: 35203772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation of Phage Lysins That Effectively Kill Pseudomonas aeruginosa in Mouse Models of Lung and Skin Infection.
    Raz A; Serrano A; Hernandez A; Euler CW; Fischetti VA
    Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 31010858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mining of Gram-Negative Surface-Active Enzybiotic Candidates by Sequence-Based Calculation of Physicochemical Properties.
    Vázquez R; Blanco-Gañán S; Ruiz S; García P
    Front Microbiol; 2021; 12():660403. PubMed ID: 34113327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequence-Function Relationships in Phage-Encoded Bacterial Cell Wall Lytic Enzymes and Their Implications for Phage-Derived Product Design.
    Vázquez R; García E; García P
    J Virol; 2021 Jun; 95(14):e0032121. PubMed ID: 33883227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bacteriophage-derived endolysins to target gram-negative bacteria.
    Lai WCB; Chen X; Ho MKY; Xia J; Leung SSY
    Int J Pharm; 2020 Nov; 589():119833. PubMed ID: 32877733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Broad Bactericidal Activity of the
    Antonova NP; Vasina DV; Lendel AM; Usachev EV; Makarov VV; Gintsburg AL; Tkachuk AP; Gushchin VA
    Viruses; 2019 Mar; 11(3):. PubMed ID: 30901901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibacterial Activity of a Novel Peptide-Modified Lysin Against Acinetobacter baumannii and Pseudomonas aeruginosa.
    Yang H; Wang M; Yu J; Wei H
    Front Microbiol; 2015; 6():1471. PubMed ID: 26733995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phage Lysins for Fighting Bacterial Respiratory Infections: A New Generation of Antimicrobials.
    Vázquez R; García E; García P
    Front Immunol; 2018; 9():2252. PubMed ID: 30459750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Three Campylobacter Lysins and Enhancement of Their Anti-Escherichia coli Efficacy Using Colicin-Based Translocation and Receptor-Binding Domain Fusion.
    Liu P; Dong X; Cao X; Xie Q; Huang X; Jiang J; Dai H; Tang Z; Lin Y; Feng S; Luo K
    Microbiol Spectr; 2023 Feb; 11(2):e0451522. PubMed ID: 36749047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro characterization of PlyE146, a novel phage lysin that targets Gram-negative bacteria.
    Larpin Y; Oechslin F; Moreillon P; Resch G; Entenza JM; Mancini S
    PLoS One; 2018; 13(2):e0192507. PubMed ID: 29408864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bacteriophage endolysins against gram-positive bacteria, an overview on the clinical development and recent advances on the delivery and formulation strategies.
    Ho MKY; Zhang P; Chen X; Xia J; Leung SSY
    Crit Rev Microbiol; 2022 May; 48(3):303-326. PubMed ID: 34478359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lysins breaking down the walls of Gram-negative bacteria, no longer a no-go.
    Gutiérrez D; Briers Y
    Curr Opin Biotechnol; 2021 Apr; 68():15-22. PubMed ID: 33053478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phages and engineered lysins as an effective tool to combat Gram-negative foodborne pathogens.
    Kocot AM; Briers Y; Plotka M
    Compr Rev Food Sci Food Saf; 2023 May; 22(3):2235-2266. PubMed ID: 37009835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lysocins: Bioengineered Antimicrobials That Deliver Lysins across the Outer Membrane of Gram-Negative Bacteria.
    Heselpoth RD; Euler CW; Schuch R; Fischetti VA
    Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30962344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engineered bacteriophage lysins as novel anti-infectives.
    Yang H; Yu J; Wei H
    Front Microbiol; 2014; 5():542. PubMed ID: 25360133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engineered endolysin-based "Artilysins" to combat multidrug-resistant gram-negative pathogens.
    Briers Y; Walmagh M; Van Puyenbroeck V; Cornelissen A; Cenens W; Aertsen A; Oliveira H; Azeredo J; Verween G; Pirnay JP; Miller S; Volckaert G; Lavigne R
    mBio; 2014 Jul; 5(4):e01379-14. PubMed ID: 24987094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.